US Stock MarketDetailed Quotes
EGRX Eagle Pharmaceuticals
- 0.950
- +0.050+5.56%
15min DelayClose Nov 22 16:00 ET
12.31MMarket Cap1.08P/E (TTM)
0.950High0.650Low12.02KVolume0.950Open0.900Pre Close10.73KTurnover0.14%Turnover Ratio0.35P/E (Static)12.96MShares9.00052wk High0.05P/B7.94MFloat Cap0.00352wk Low--Dividend TTM8.36MShs Float104.170Historical High--Div YieldTTM33.32%Amplitude0.003Historical Low0.892Avg Price1Lot Size
About Eagle Pharmaceuticals Company
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Company Profile
SymbolEGRX
Company NameEagle Pharmaceuticals
Listing DateFeb 12, 2014
Issue Price15.00
Founded2007
CEOMr. Michael Graves
MarketPink Market
Employees134
Fiscal Year Ends12-31
Address50 Tice Boulevard,Suite 315
CityWoodcliff Lake
ProvinceNew Jersey
CountryUnited States of America
Zip Code07677-9991
Phone1-201-326-5300
Websitehttp://www.eagleus.com
Company Executives
- Name
- Position
- Salary
- Steven B. Ratoff
- Interim Chief Financial Officer, Principal Accounting Officer and Independent Director
- 331.03K
- Michael Graves
- Interim Executive Chairman of the Board and Interim Principal Executive Officer
- 391.03K
- Robert L. Glenning
- Independent Director
- 324.78K
- Dr. Jennifer K Simpson, PhD
- Independent Director
- 308.53K
- Richard A. Edlin
- Independent Director
- 312.28K
- Dr. Luciana Borio, M.D.
- Independent Director
- 308.53K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data